Medication Abortion

A systemic review of “no-test” medication abortion, using an allis clamp during IUD placement, a trial of gabapentin for pain management during second-trimester abortions, and at-home urine pregnancy testing for follow-up of immediate management of an undesired pregnancy of unknown location.

How primary care providers can support increased abortion access for all.

#IUD on TikTok, factors associated with pain during medication abortion, continuation rates of IUDs placed as EC at one year, and racial differences in birth control method provision for adolescents.

Health care provider misconceptions about birth control as an abortifacient, a comprehension study of an over-the-counter combination birth control pill label, an updated Consensus from ACOG on menstrual suppression, and the effect of state-level abortion restrictions on early pregnancy loss management.

Trends in bHCG levels after medication abortion, a novel implant removal device, trends in IUD self-removal during the COVID-19 pandemic, and support for the patient-centeredness of telehealth birth control and abortion care.

Pain management for medication abortion, support for eight years of use for a LNG 52mg IUD (Mirena and Liletta), IUD placement within 48 hours after medication abortion, and more.

Management of retained products of conception and a comparison of buccal and vaginal misoprostol for medication abortion, contraceptive values and preferences of adolescents and young adults, and more.

Novel ulipristal-releasing copper IUD, internal medicine physicians’ provision of medication abortion in a primary care setting, analysis of contraceptive decision aids for adolescents and young adults, and more.